Voyager Therapeutics
VYGR
$7.62
Share price
2.70%
Change (1 day)
2.42%
Change (1 year)
Voyager Therapeutics (VYGR) - Cash on Hand
Cash on Hand as of December 2023 : $0.23 B
According to Voyager Therapeutics
's latest financial reports the company has $0.23 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Voyager Therapeutics - Cash on Hand chart (from 2014 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.23 B | 94.26% |
| 2022-12-31 | $0.11 B | -10.33% |
| 2021-12-31 | $0.13 B | -26.83% |
| 2020-12-31 | $0.18 B | -35.66% |
| 2019-12-31 | $0.28 B | 80.69% |
| 2018-12-31 | $0.15 B | -7.84% |
| 2017-12-31 | $0.16 B | -3.08% |
| 2016-12-31 | $0.17 B | -10.25% |
| 2015-12-31 | $0.19 B | 2662.43% |
| 2014-12-31 | $7.03 M | 5111.11% |
| 2013-12-31 | $0.13 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -9.83% | 🇺🇸 USA |